Diagnostic tunnel vision by 2 pulmonologists led to a $2 million malpractice settlement after the patient died of esophageal cancer.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Estimate your federal taxes with our 1040 tax calculator and earn ...

Vergent Bioscience has launched the Phase 3 VISUALIZE 2 trial evaluating abenacianine, a tumor-activated imaging agent designed to enhance intraoperative tumor detection in lung cancer surgery. The ...

Studies are showing that the inflammatory condition can impact organs across the body, not just those involved in ...

Manchester University NHS Foundation Trust is nearly doubling biopsy capacity in lung cancer diagnostics with a bespoke, end-to- ...

A two-week-old baby was hospitalized at Wolfson after contracting herpes during a circumcision involving direct oral suction.

Vergent Bioscience, a clinical-stage biotechnology company advancing molecularly targeted intraoperative imaging, today announced the initiation of VISUALIZE 2, a Phase 3, multi-center, pivotal study ...

Skin cancer is one of the most common types of cancer globally. Despite the remarkable advancements of deep learning methods in computer vision, automatic diagnosis of skin diseases still faces ...

KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, has discovered how cancer cells can ...

L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a global leader in AI, Digital & R&D Consulting Services, has announced its next-generation, AI-powered digital twin plat ...

Imagine you go to the healthcare provider because you have a bad cough, or maybe you fell and hurt your ribs.

L&T Technology Services has launched an AI-based lung digital twin platform designed for lung navigation, surgical planning, ...